About Evaluate’s CI Consulting Practice

Your Tech-Enabled Partner in
Competitive Intelligence

Strategic competitive intelligence (CI) in the pharma industry is a crucial but time consuming and complex task. Tracking R&D and marketed products across multiple indications, monitoring competing companies and assets, and identifying gaps in the market require a combination of data, intelligence, insight and therapy area expertise. Evaluate’s CI practice provides you with a technology-enabled extension of your team to ensure your team are free to focus on the areas that will achieve your strategic goals.

How we help

Expert-Driven CI Insights

Our team of 70+ consultants and analysts are experienced in a wide range of therapy areas – from oncology to vaccines to cell and gene therapies and beyond. Their expertise ensures we provide you with timely, accurate and actionable insights, supported by comprehensive data from across the wider Norstella group.

Tech-enabled Solutions

Our customisable, tech-enabled analytics combine key CI data points to release CI teams from the burden of manual reporting. We provide best in class insights based on the most robust data sets – overlaid with domain expertise from our consultants.

Collaborative Partnership Model

As your needs evolve, our team is on-hand to expand coverage, develop customised visualisations and deliver strategic insights that answer the questions that keep your executives awake at night. Never prescriptive, we work to meet you where you are – providing an outside perspective on your market, to strengthen your strategic decision-making.